Skip to content
★ Sign in to follow
JF

John F. Rex

Chief Financial Officer
Insider activity · 24 months1 buy0 salesCumulative net flow
Total declarations
127
Company
1
▲ Purchases (1 ops.)
€4.5M
▼ Sales (4 ops.)
€18.4M

Latest filing published 26 Jun 2025 for Unitedhealth Group INC.

Filing timeline

BuySale
John F. Rex

Insider track record

Disclosed buys
1
Disclosed sells
4
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 16 May 2025 · 542 days ago · €4.5M
    +23.8%
    Entry US$315.89 · Close at T+365 US$391.13

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

John F. Rex: trading record in brief

John F. Rex, EVP Chief Financial Officer of Unitedhealth Group Inc, has filed 127 times between June 9, 2016 and June 26, 2025, 117 of them grants. The market side comes down to 5 trades: 1 purchase of EUR 4,467,128 on May 16, 2025, which makes up 20% of market trades, and 4 sales totaling EUR 18.4 million, with a median of EUR 4,451,946. The largest are from July 29, 2022 (EUR 7,004,278), July 17, 2020 (EUR 6,003,386) and July 29, 2021 (EUR 2,900,507). The record adds 4 option exercises.

Filings are regular, from 12 to 16 a year from 2017 to 2025, after only 4 in 2016. None falls in the last 12 months.

At Unitedhealth Group Inc, 5 of Rex's trades are within 30 days of a trade by Stephen J. Hemsley, 3 of one by Andrew Witty and 3 of one by Richard T. Burke, all in the same direction. The median publication delay is 2 days.

Companies and markets linked to John F. Rex

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations127 total

25 of 127 declarations